New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A2437

Introduced
1/9/24  
Refer
1/9/24  
Report Pass
10/17/24  
Engrossed
10/28/24  
Refer
12/5/24  
Report Pass
12/12/24  
Refer
12/12/24  
Report Pass
2/3/25  
Engrossed
12/22/25  
Enrolled
12/22/25  
Chaptered
1/12/26  

Caption

Requires ingredients of menstrual products to be listed on package.

Impact

By enforcing ingredient disclosure, A2437 would amend existing consumer protection laws, thereby significantly impacting state regulation of health and personal care products. Critics have argued that the bill may impose burdensome requirements on manufacturers, especially small businesses that may not have the resources to comply quickly. However, supporters assert that such transparency is essential for consumer protection, as it empowers individuals to make safer choices regarding their health. The legislation aligns with broader trends in health safety and environmental awareness, as consumers increasingly demand to know what they are putting in and on their bodies.

Summary

Assembly Bill A2437 aims to enhance transparency regarding menstrual products by mandating that all manufacturers disclose the ingredients used in their products on the packaging. This legislation is pivotal for consumers, particularly those seeking to avoid specific chemicals due to allergies, health concerns, or personal values. The bill stipulates that the ingredients must be listed in descending order of predominance, making it easier for consumers to make informed choices about the products they use. Additionally, the bill requires that these ingredient lists be available on manufacturers' websites, thereby increasing accessibility to this critical information.

Sentiment

The sentiment surrounding A2437 is largely positive among consumer advocacy groups and health-conscious consumers who are in favor of greater transparency. These groups praise the bill as a critical step toward ensuring product safety and consumer rights. Conversely, some industry representatives express concerns that the new regulations could lead to increased costs and complicate the manufacturing process. The public discussions have highlighted the necessity of balancing consumer rights with fair business practices, underlying a fundamental conflict in regulatory approaches within the state.

Contention

Notable points of contention in the discussions surrounding A2437 include debates over the definition of 'confidential business information'. Manufacturers worry that the broad interpretation could jeopardize proprietary formulations, while advocates insist that consumer safety must take precedence. There are also discussions about the timeline for compliance, with concerns from various stakeholders about the feasibility of implementing the required changes within the specified timeframe. Overall, this legislation represents a significant shift towards prioritizing transparency in consumer health products, weighing both the potential benefits and challenges of such requirements.

Companion Bills

NJ S3643

Same As Requires ingredients of menstrual products to be listed on package.

NJ A1685

Carry Over Requires ingredients of menstrual products to be listed on package.

NJ A3854

Carry Over Requires menstrual products include ingredient list; requires toxic shock syndrome warnings be printed on tampon package.

Previously Filed As

NJ A1940

Requires ingredients of menstrual products to be listed on package.

NJ A3125

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

NJ A3104

Establishes "Menstrual Hygiene Products Program," appropriates $200,000.

NJ A2190

Requires certain libraries to provide free menstrual hygiene products and requires State to pay costs.

NJ A3106

Establishes requirements for State to enter into contract for purchase of menstrual products.

NJ A1166

Requires State Police to establish recovery leave policy for troopers presenting proof of pregnancy.

NJ A2197

Establishes Women's Menstrual Health Program to identify and assist patients with symptoms related to endometriosis and polycystic ovary syndrome.

NJ A2046

Provides gross income tax deduction to eligible educators and paraprofessionals for expense of classroom supplies.

NJ A2185

Requires public institutions of higher education to provide menstrual products in all campus buildings; appropriates $85,000 from General Fund to Office of Secretary of Higher Education.

NJ A2354

Eliminates smoking ban exemption for casinos and simulcasting facilities.

Similar Bills

NJ A1940

Requires ingredients of menstrual products to be listed on package.

NJ A2182

Requires school districts to permit students excused absences while experiencing symptoms of menstrual disorder.

NJ A2183

Requires school districts to provide instruction on menstrual health and hygiene as part of implementation of New Jersey Student Learning Standards in Comprehensive Health and Physical Education.

NJ A3105

Requires certain public schools to advertise availability of free menstrual hygiene products.

NJ A2184

Permits students experiencing menstrual disorder to attend school remotely.

NJ A3125

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

NJ A3103

Requires DHS to establish a pilot program covering menstrual hygiene products under Medicaid and NJ FamilyCare.

NJ A2197

Establishes Women's Menstrual Health Program to identify and assist patients with symptoms related to endometriosis and polycystic ovary syndrome.